SIGI
TEVA icon

Susquehanna International Group (Ireland)’s Teva Pharmaceuticals TEVA Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38,457
Closed -$345K – 33
2020
Q1 		$345K Buy
+38,457
New +$394K 0.28% 21

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group (Ireland)'s TEVA Position: Q2 2020 in Review

Susquehanna International Group (Ireland) sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 38,457 shares — an estimated $345K sold.

Susquehanna International Group (Ireland) first reported a position in TEVA in Q1 2020 and held it in 1 quarter. The position peaked at $345K in Q1 2020. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Susquehanna International Group (Ireland) reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 38,457 Teva Pharmaceuticals shares in Q2 2020, an estimated $345K.
  • Susquehanna International Group (Ireland) first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Susquehanna International Group (Ireland)'s Teva Pharmaceuticals position peaked at $345K in Q1 2020.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q2 2020, filed 14 Aug 2020.